Silica-associated systemic lupus erythematosus in an elderly man

Internal Medicine

Volumn 46, Issue 22, 2007, Pages 1867-1871

  Yamazaki, Seiichi ^a   Yoshiike, Fumiaki ^a   Hirai, Kazuya ^a   Kakegawa, Tetsuji ^a   Ikeda, Michiyo ^a   Nagata, Atsuo ^a   Saito, Gaku ^a   Nishimura, Hideki ^a   Hosaka, Noriko ^a   Ehara, Takashi ^b  

^a Nagano Municipal Hospital   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune disease; Lupus nephritis; Silica; Silicosis

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; DOUBLE STRANDED DNA ANTIBODY; GALLIUM; GLUCOCORTICOID; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISOLONE; SILICON DIOXIDE;

AGED; ARTICLE; CASE REPORT; COAL WORKER; ELECTRON MICROSCOPY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; FOCAL GLOMERULONEPHRITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG LAVAGE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHADENOPATHY; LYMPHOCYTOPENIA; LYMPHOSCINTIGRAPHY; MALAISE; MALE; MEDIASTINUM LYMPH NODE; OCCUPATIONAL EXPOSURE; PROTEINURIA; SILICOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

AGED; GLUCOCORTICOIDS; HUMANS; LUNG; LUPUS NEPHRITIS; MALE; METHYLPREDNISOLONE; PREDNISOLONE; SILICON DIOXIDE; SILICOSIS;

EID: 36749042515     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0015     Document Type: Article

References (27)

1. Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis 1: 6, 2006.
2. Conrad K, Mehlhorn J, Luthke K, Dorner T, Frank KH. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines; clinical and serological characteristics. Lupus 5: 62-69, 1996.
3. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56: 481-490, 2003.
4. Caplan A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 8: 29-37, 1953.
5. Suratt PM, Winn WC Jr, Brody AR, Bolton WK, Giles RD. Acute silicosis in tombstone sandblasters. Am Rev Respir Dis 115: 521-529, 1977.
6. Cledes J, Herve JP, Clavier J, Youinou P, Ollivier JP. Pulmonary silicosis and disseminated lupus erythematosus. Poumon Coeur 39: 205-207, 1983 (in French, Abstract in English).
7. Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nunez-Roldan A. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 52: 534-538, 1993.
8. Koeger AC, Lang T, Alcaix D, et al. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 74: 221-237, 1995.
9. Rosenman KD, Moore-Fuller M, Reilly MJ. Connective tissue disease and silicosis. Am J Ind Med 35: 375-381, 1999.
10. Costallat L, De C, Zambon L. Pulmonary silicosis and systemic lupus erythematosus in men: a report of two cases. Joint Bone Spine 69: 68-71, 2002.
11. Parks CG, Cooper GS, Nylander-French LA, et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum 46: 1840-1850, 2002.
12. Alarcon GS, Friedman AW, Straaton KV, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus 8: 197-209, 1999.
13. Struhar D, Harbeck RJ, Mason RJ. Lymphocyte populations in lung tissue, bronchoalveolar lavage fluid, and peripheral blood in rats at various times during the development of silicosis. Am Rev Respir Dis 139: 28-32, 1989.
14. Doll NJ, Stankus RP, Hughes J, et al. Immune complexes and autoantibodies in silicosis. J Allergy Clin Immunol 68: 281-285, 1981.
15. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41: 1241-1250, 1998.
16. Cohen PL, Eisenberg RA. Lpr and gld; single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9: 243-269, 1991.
17. Otsuki T, Miura Y, Nishimura Y, et al. Alterations of Fas and Fas-related molecules in patients with silicosis. Exp Biol Med (Maywood) 231: 522-533, 2006.
18. Ueki A. Fas-Fas ligand system in silicosis patients. Nippon Eiseigaku Zasshi 55: 474-480, 2000 (in Japanese, Abstract in English).
19. Tomokuni A, Otsuki T, Isozaki Y, et al. Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol 118: 441-444, 1999.
20. Dosreis GA, Borges VM, Zin WA. The central role of Fas-ligand cell signaling in inflammatory lung diseases. J Cell Mol Med 8: 285-293, 2004.
21. Borges VM, Falcao H, Leite-Junior JH, et al. Fas ligand triggers pulmonary silicosis. J Exp Med 194: 155-164, 2001.
22. Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 107 (Suppl 5): 793-802, 1999.
23. Moseley PL, Monick M, Hunninghake GW. Divergent effects of silica on lymphocyte proliferation and immunoglobulin production. J Appl Physiol 65: 350-357, 1988.
24. Davis GS, Pfeiffer LM, Hemenway DR. Persistent overexpression of inkerleukin-1 beta and tumor necrosis factor-alpha in murine silicosis. J Environ Pathol Toxicol Oncol 17: 99-114, 1998.
25. Driscoll KE, Carter JM, Hassenbein DG, Howard B. Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect 105(supply 5): 1159-1164, 1997.
26. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 50: 849-857, 2004.
27. Freemer MM, King TE Jr, Criswell LA. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis 65: 581-584, 2006.